CLINICAL_TRIALS
trial_result
· 2011-11-11
Clinical Trial Update: High Dose Ribavirin in the Treatment of Chronic Hepatitis C [Phase 2]
Summary
A completed Phase 2 clinical trial evaluating high-dose ribavirin for chronic hepatitis C.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Bern | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED